Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,909 | -16,741 | -83,189 | -65,073 | -47,030 |
| Depreciation Amortization | 136 | 67 | 287 | 224 | 159 |
| Accounts receivable | 1,169 | 307 | -693 | 392 | 35 |
| Accounts payable and accrued liabilities | -315 | -1,367 | -1,249 | -2,370 | 1,681 |
| Other Working Capital | -754 | -3,494 | -5,468 | -3,314 | 829 |
| Other Operating Activity | 6,131 | 5,236 | 13,605 | 10,016 | 5,048 |
| Operating Cash Flow | $-27,542 | $-15,992 | $-76,707 | $-60,125 | $-39,278 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -175 | -72 | -838 | -702 | -714 |
| Investing Cash Flow | $-175 | $-72 | $-838 | $-702 | $-714 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -4,646 | -4,646 | -4,646 |
| Common Stock Issued | 116 | 15 | 167,061 | 166,890 | 165,675 |
| Financing Cash Flow | $116 | $15 | $162,415 | $162,244 | $161,029 |
| Beginning Cash Position | 205,912 | 205,912 | 121,042 | 121,042 | 121,042 |
| End Cash Position | 178,311 | 189,863 | 205,912 | 222,459 | 242,079 |
| Net Cash Flow | $-27,601 | $-16,049 | $84,870 | $101,417 | $121,037 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,542 | -15,992 | -76,707 | -60,125 | -39,278 |
| Capital Expenditure | -175 | -72 | -838 | -702 | -714 |
| Free Cash Flow | -27,717 | -16,064 | -77,545 | -60,827 | -39,992 |